OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
Share:
HOUSTON - OrthoAccel® Technologies, Inc. announced this week that it has finalized a distribution agreement with Micerium S.p.A. based in Avegno for exclusive distribution rights of the AcceleDent(TM) System in Italy.
The AcceleDent(TM) System is currently being sold outside the USA and was first introduced in the United Kingdom in October 2009. The lightweight appliance, used to speed up the rate of orthodontic treatment, is intended for 20 minutes of daily use. Patients simply bite down on the Mouthpiece to hold it in place, which allows freedom of the hands to engage in other routine, daily activities during the treatment session. Patients have reported using the appliance while engaged in a variety of activities, including homework, watching television, reading and listening to music.
Mike Kaufman, Vice President of Marketing and Business Development for OrthoAccel® commented, "Micerium is the most recent addition to our growing network of European distributors. Italy is a key international market for us and it bodes well that this market leader shares our philosophy and excitement for how AcceleDent(TM) can change orthodontic treatment." AcceleDent(TM) was introduced to the Italian orthodontic community during the SIDO meeting in Rome November 11-13. Dr. Ravindra Nanda reported on the recent results from a randomized, controlled clinical trialconducted at the University of Texas Health Science Center at San Antonio under the guidance of Dr. Dubravko Pavlin where AcceleDent(TM) demonstrated, with statistical significance, that tooth movement could be safely accelerated by 38% to 50% during space closure and even more so during the alignment phase.
This definitive distribution agreement between OrthoAccel®and Miceriumformalizes the intent to partner together that was initiated under a Terms of Agreement in June of this year. Ottaviano Miceli, CEO of Micerium, expressed his enthusiasm, "I am excited about this new project. Our company has always paid attention to market innovations and we believe that AcceleDent is great news - a simple product that will bring many benefits to the orthodontic treatment in terms of time savings and results. In a short time we have already seen a great interest and desire to discover and try AcceleDent by the Italian orthodontists who want to offer the best treatment to their patients."
OrthoAccel® has been selling the AcceleDent(TM) System outside the USA since October 2009. FDA clearance is pending based on an application submitted earlier this year.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent(TM) System
AcceleDent(TM) represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating bone biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent(TM) is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via info@orthoaccel.com
SOURCE OrthoAccel Technologies, Inc.
CONTACT: Michael K. Lowe, CEO of OrthoAccel Technologies, Inc., +1-832-631-1659
Web Site: www.acceledent.com
